Myriant Senior Management to Participate at the 2012 BIO International Convention

Boston, MA (June 13, 2022) -Myriant Corporation today announced that members of its management team will participate in the 2012 BIO International Convention in Boston, MA. Myriant Chairman and CEO, Stephen J. Gatto will participate at BIO's Press Conference on Monday, June 18, at 3:00 p.m. EST. Also, Myriant Senior Vice President of Corporate Communications and Government Affairs, Susan Hager, will be part of a panel titled, "Financing Advanced Biofuels and Integrated Biorefineries," on Tuesday, June 19, from 2:00 p.m. to 3:30 p.m. EST. The 2012 BIO International Convention will be held from June 18th - June 21st, at the Boston Convention & Exhibition Center, Massachusetts.

About Myriant Corporation

Myriant utilizes its proprietary technology platform to develop innovative, performance-based, renewable chemicals utilizing low-cost sugars. In December 2010, Myriant broke ground on its flagship 30 million pound commercial bio-succinic acid facility in Lake Providence, Louisiana and anticipates beginning commercial production in early 2013. The company's D(-) lactic acid started production at commercial scale in June 2008 for use in polylactic acid. Myriant has agreements with ThyssenKrupp Uhde GmbH for engineering, Davy Process Technology for the integration of Myriant's bio-succinic acid process with the Davy butanediol process for the production of bio-based butanediol, and PTT Chemical for the commercialization of Myriant's technology in Southeast Asia. Myriant is headquartered in Quincy, Massachusetts. Details are available at


Sue Hager SVP, Corporate Communications and Government Affairs
Myriant Corporation